St. Joseph's University Medical Center is a member of St. Joseph's Health. Located in Paterson, New Jersey, St. Joseph's University Medical Center, which includes St. Joseph's Children's Hospital, is a major academic medical center and state designated trauma center that cares for the most complex and routine cases.

During the past decade, Saint Joseph's Regional Medical Center conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 64 clinical trials were completed, i.e. on average, 130.6% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 29 clinical trials were completed. i.e. 152.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Joseph's Regional Medical Center" #1 sponsor was "Children's Oncology Group" with 68 trials, followed by "National Cancer Institute (NCI)" with 34 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored and "Abbott Medical Devices" with 4 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph's Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 73 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Children's Oncology Group" with 3 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Canadian Cancer Trials Group" with 2 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Saint Joseph's Regional Medical Center" are "HIV Infections" (15 trials), "Acute Lymphoblastic Leukemia" (8 trials), "Acute Myeloid Leukemia" (5 trials), "B Acute Lymphoblastic Leukemia" (5 trials) and "Localized Resectable Neuroblastoma" (5 trials). Many other conditions were trialed in "Saint Joseph's Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Saint Joseph's Regional Medical Center" are "Drug" (106 trials), "Other" (80 trials), "Biological" (47 trials), "Procedure" (45 trials) and "Radiation" (38 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (52 trials), "Cyclophosphamide" (46 trials), "Vincristine Sulfate" (34 trials), "Doxorubicin Hydrochloride" (29 trials) and "Etoposide" (28 trials). Other intervention names were less common.

The vast majority of trials in "Saint Joseph's Regional Medical Center" are 142 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Joseph's Regional Medical Center". undefined are not yet recruiting, 28 are recruiting, 51 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 62 completed trials in Saint Joseph's Regional Medical Center, 2 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Joseph's Regional Medical Center, 10 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".

Saint Joseph's Regional Medical Center has several departments that took part in Clinical trials: "St. Joseph's Children's Hospital" - 9 trials, "Saint Joseph's WIC Program" - 2 trials